T1	p 65 86	severe bronchiectasis
T2	p 433 484	Twenty-four patients ( 12 female ; mean age 51 yr )
T3	p 1469 1483	bronchiectasis
T4	i 14 25	fluticasone
T5	i 316 334	placebo-controlled
T6	i 401 412	fluticasone
T7	i 531 542	fluticasone
T8	i 612 619	placebo
T9	i 979 990	fluticasone
T10	i 1007 1018	fluticasone
T11	i 1041 1048	placebo
T12	o 34 61	sputum inflammatory indices
T13	o 216 250	inflammatory and infective markers
T14	o 638 718	spirometry , 24-h sputum volume , sputum leukocyte density , bacterial densities
T15	o 725 819	concentrations of interleukin ( IL ) -1beta , IL-8 , tumor necrosis factor-alpha ( TNF-alpha )
T16	o 826 849	leukotriene B4 ( LTB4 )
T17	o 917 941	sputum leukocyte density
T18	o 946 961	IL-1beta , IL-8
T19	o 968 972	LTB4
T20	o 1125 1135	spirometry
T21	o 1165 1182	adverse reactions
T22	o 1288 1315	sputum inflammatory indices